Nizatidine

CAS No. 76963-41-2

Nizatidine( LY139037 )

Catalog No. M15911 CAS No. 76963-41-2

Nizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 49 In Stock

Biological Information

  • Product Name
    Nizatidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Nizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.
  • Description
    Nizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.(In Vivo):Nizatidine (oral gavage; 27 mg/kg; once daily; at 12 weeks of age and were sacrificed at 30 weeks after development of HCC in the setting of nonalcoholic steatohepatitis (NASH)) results in a 35% reduction of tumor nodules relative to controls. Nizatidine results in a 60% reduction in tumor nodules, reduces collagen proportional area and expression of profibrotic markers in DEN-injured rats.Nizatidine (oral gavage; 27 mg/kg; once daily; 4 weeks) decreases the incidence of gastric ulceration, and significantly decreases the mean ulcer score and ulcer index in male albino rats.
  • In Vitro
    ——
  • In Vivo
    Nizatidine (oral gavage; 27 mg/kg; once daily; at 12 weeks of age and were sacrificed at 30 weeks after development of HCC in the setting of nonalcoholic steatohepatitis (NASH)) results in a 35% reduction of tumor nodules relative to controls. Nizatidine results in a 60% reduction in tumor nodules, reduces collagen proportional area and expression of profibrotic markers in?DEN-injured rats.Nizatidine (oral gavage; 27 mg/kg; once daily; 4 weeks) decreases the incidence of gastric ulceration, and significantly decreases the mean ulcer score and ulcer index in male albino rats. Animal Model:Male albino ratsDosage:27 mg/kgAdministration:Oral gavage; 27 mg/kg; once daily; 4 weeks Result:Was effective in the management of NSAIDs induced peptic ulcer in rats.
  • Synonyms
    LY139037
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    AChE| H2 receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    76963-41-2
  • Formula Weight
    331.46
  • Molecular Formula
    C12H21N5O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 18 mg/mL (54.3 mM); Water: 28 mg/mL (84.47 mM); DMSO: 66 mg/mL (199.11 mM)
  • SMILES
    CN/C(NCCSCC1=CSC(CN(C)C)=N1)=C\[N+]([O-])=O
  • Chemical Name
    (E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lin TM, et al. J Pharmacol Exp Ther, 1986, 239(2), 406-410.
molnova catalog
related products
  • Syn-Ake acetate

    Syn-Ake acetate is a muscarinic acetylcholine receptor antagonist.

  • Pirimiphos-methyl

    Pirimiphos-methyl is a rapid-acting organophosphorus insecticide and acaricide, causing inhibition of AChE in target organisms.

  • Nicotine

    Nicotine is the primary pharmacologic component of tobacco. It acts on nicotinic acetylcholine receptors (nAChRs) in the peripheral nervous system (autonomic ganglia and adrenal medulla neuromuscular junction) and the central nervous system (CNS).